Skip to main content
Melissa Alsina, MD, Hematology, Tampa, FL

MelissaAlsinaMD

Hematology Tampa, FL

Assistant Professor of Medicine, University S Fla College of Medicine

Overview of Dr. Alsina

Dr. Melissa Alsina is a hematologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from University of Puerto Rico School of Medicine and has been in practice 29 years. Dr. Alsina accepts several types of health insurance, listed below. She is one of 46 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Hematology. She has more than 100 publications and over 500 citings.

Education & Training

  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1992 - 1995
  • San Juan City Hospital
    San Juan City HospitalFellowship, Hematology and Medical Oncology, 1991 - 1992
  • VA Caribbean Healthcare System
    VA Caribbean Healthcare SystemResidency, Internal Medicine, 1988 - 1991
  • University of Puerto Rico School of Medicine
    University of Puerto Rico School of MedicineClass of 1988

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2000 - 2026
  • PR State Medical License
    PR State Medical License 2010 - 2022
  • OK State Medical License
    OK State Medical License 1996 - 2002
  • TX State Medical License
    TX State Medical License 1996 - 2002
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy
    Melissa Alsina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The Result of a Phase 1 Study of Selinexor in Combination with High-Dose Melphalan and Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
    Melissa Alsina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Panobinostat As a Maintenance Therapy after Autologous Hematopoietic Cell Transplantation for Patients with Multiple Myeloma
    Melissa Alsina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Press Mentions

  • BCMA-Directed CAR-T Therapy Shows Clinical Activity in Multiple Myeloma
    BCMA-Directed CAR-T Therapy Shows Clinical Activity in Multiple MyelomaDecember 7th, 2020
  • Ash 2020 – Efficacy and Deaths Mark the Car-T Multiple Myeloma Race
    Ash 2020 – Efficacy and Deaths Mark the Car-T Multiple Myeloma RaceDecember 5th, 2020
  • Bluebird Bio to Present Data from Gene and Cell Therapy Programs During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
    Bluebird Bio to Present Data from Gene and Cell Therapy Programs During the 62nd American Society of Hematology (ASH) Annual Meeting and ExpositionNovember 5th, 2020
  • Join now to see all

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AvMed Health Open Access
    BCBS Blue Card PPO
    BCBS California CaliforniaCare HMO
    BCBS California PowerSelect HMO
    BCBS California PPO
    BCBS Florida BlueCare HMO
    BCBS Florida NetworkBlue
    BCBS Florida Preferred Patient Care PPO
    Blue Shield CA Local Access Plus HMO
    Blue Shield California HMO
    Blue Shield California PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Connecticare FlexPOS
    Coventry Florida - Employer Group PPO
    First Health PPO
    Great West PPO
    Health Net California Large Group PPO
    Health Net HMO - Employer Group
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PHCS PPO - Kaiser
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    Pacificare HMO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment